The Oncology Institute, Inc. (TOI) Reports Q1 Loss of $0.21, provides guidance

The Oncology Institute, Inc. (NASDAQ: TOI) reported Q1 EPS of ($0.21). Revenue for the quarter came in at $104.4 million, versus $0 reported last year.

GUIDANCE:

The Oncology Institute, Inc. sees FY2025 revenue of $460-480 million, versus the consensus of $482.8 million.

For earnings history and earnings-related data on The Oncology Institute, Inc. (TOI) click here.

You May Also Be Interested In

• Morgan Stanley upgrades CDW on stronger AI-driven server demand
• BofA lists top 5 themes driving next $1tn in incremental semi sales
• DOJ Unveils $6.5B Healthcare Fraud Crackdown - WSJ